Eagle Health Investments’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33M Hold
187,413
– – 5.46% 6
2026
Q1
$23.1M Sell
187,413
-43,748
-19% -$5.74M 4.04% 9
2025
Q4
$30.3M Sell
231,161
-91,100
-28% -$10.7M 6.66% 5
2025
Q3
$30.6M Sell
322,261
-21,100
-6% -$2.09M 8.03% 5
2025
Q2
$32.8M Hold
343,361
– – 8.09% 4
2025
Q1
$27.2M Hold
343,361
– – 7.07% 5
2024
Q4
$45.9M Sell
343,361
-43,993
-11% -$6.26M 11.25% 3
2024
Q3
$50.5M Buy
387,354
+68,600
+22% +$8.46M 9.57% 2
2024
Q2
$33.3M Sell
318,754
-8,925
-3% -$1M 5.83% 7
2024
Q1
$43.8M Hold
327,679
– – 8.13% 3
2023
Q4
$44.4M Buy
327,679
+206,476
+170% +$23.8M 9.02% 2
2023
Q3
$16.2M Sell
121,203
-48,725
-29% -$8.01M 3.57% 14
2023
Q2
$31M Sell
169,928
-43,353
-20% -$8.78M 5.79% 5
2023
Q1
$48.2M Buy
213,281
+71,505
+50% +$14.6M 9.39% 1
2022
Q4
$27.9M Sell
141,776
-77,395
-35% -$16M 6.43% 7
2022
Q3
$40.7M Buy
219,171
+96,728
+79% +$19.1M 9.34% 1
2022
Q2
$22M Buy
+122,443
New +$31.3M 5.12% 7
2021
Q1
– Sell
-16,140
Closed -$5.81M – 27
2020
Q4
$5.81M Buy
+16,140
New +$5.15M 3.72% 12

Other funds holding ILMN

Eagle Health Investments's ILMN Position: Q2 2026 in Review

Eagle Health Investments held its Illumina (ILMN) position steady in Q2 2026 at 187,413 shares worth $33M. The position accounts for 5.46% of the portfolio, ranked #6.

Eagle Health Investments first reported a position in ILMN in Q4 2020 and has held it in 18 quarters since. The position peaked at $50.5M in Q3 2024. 939 funds tracked by Wall St. Rank hold ILMN as of Q2 2026.

  • Eagle Health Investments held 187,413 shares of Illumina worth $33M as of Q2 2026.
  • Eagle Health Investments left its Illumina share count unchanged in Q2 2026.
  • Illumina made up 5.46% of Eagle Health Investments's portfolio in Q2 2026, its #6 holding.
  • Eagle Health Investments first reported a position in Illumina in Q4 2020 and has held it in 18 quarters since.
  • Eagle Health Investments's Illumina position peaked at $50.5M in Q3 2024.
  • 939 funds tracked by Wall St. Rank held Illumina as of Q2 2026.

Based on Eagle Health Investments's 13F filing for Q2 2026, filed 10 Aug 2026.